National Strategic plan on 90-90-90

The main goal is to realize the 90-90-90 global goal. The key strategies for each priority area are as follows:

HIV Prevention

  • To reduce HIV incidence by implementing interventions that target major sources of new infections, namely heterosexual relationships, casual heterosexual sex, and KVP and STI management.
  • Sustaining gains in condom distribution to ensure availability and accessibility
  • of condoms in public and private outlets and distributed more effectively to reach all populations in need.
  • Enhanced male involvement aimed at increasing awareness about the critical role of men in the success of HIV prevention interventions and influencing behaviour change that supports HIV prevention efforts.
  • Enhancing prevention strategies that reducing the risk of HIV exposure through blood borne infection including through injecting drug use, in health care settings and mother-to-child transmission and improving blood safety by ensuring greater efficiency of national blood transfusion services.
  • Rigorous SBCC to address societal causes of HIV risk, vulnerability of young people, particularly young girls and stigma and discrimination against PLHIV and populations at highest risk.
  • For secondary prevention, the strategic plan contains a cluster of HIV prevention strategies centred on ART including PMTCT, PEP and PreP as well as routine viral load monitoring and suppression to enhance the preventive effect of ART.
  • Increased efficiency of HTS for co-infections and co-morbidity including TB/HIV, Hepatitis /HIV.
  • Integration of HIV prevention services including joint planning, joint supervision, joint training activities, co-location of ART, TB and RMNCH services (“one stop shop”) to facilitate service integration and promote efficiency.

Care, treatment and Support

  • Ensure universal coverage of CTC services in all public, faith based and private health facilities.
  • Strengthen mechanisms for linkage from HIV testing services to care for all HIV positive individuals and entry points for HIV exposed infants, pregnant women, children, adolescents and men
  • Strengthen community level follow-up and treatment support mechanisms for PLHIV on pre-ART and ART care.
  • Enhance early initiation into ART and adherence support services for all PLHIV with special focus on adolescents and elderly
  • Intensified action to enhance EID specifically targeting children with perinatal HIV infection.
  • Reduce barriers to the provision of ART to KVP including provider (institutionalized) discrimination.
  • Strengthen and improve integrated prevention, screening and management of TB reproductive cancers and other co-morbidities within CTCs and other HIV/AIDS services.

Health Systems strengthening

  • Rectifying weaknesses in health care delivery systems that are slowing the scale-up of HIV treatment programmes to helping drive improvements in health care infrastructure, such as procurement and cold chain systems, laboratory systems, health information systems, monitoring and evaluation.
  • Mobilize resources to support efforts to ensure universal access to HIV and AIDS Care and Treatment services, including the number of health facilities with CTC services and RCH clinics that provide Option B+ for pregnant women.
  • Continue providing community-based care and support to both bedridden clients as well as ambulatory individuals for adherence to treatment.
  • M&E to ensure evidence-informed programming and decision making will be given priority in the HSHSP. HSHSP IV) 2017–2022 xvii
  • The mobilization of financial and human resources necessary for accomplishing the above strategies.